Largest pharmaceutical companies in the United States by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Johnson & Johnson leads the 36 pharmaceutical companies in the United States ranked by revenue, at TRY 4.76T, ahead of Eli Lilly (TRY 3.3T) and Merck & Co (TRY 3.29T). Figures as of 20 Nov 2026, 20:09 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 36
- First
- Johnson & JohnsonTRY 4.76T
- Median
- TRY 69.8B
- Combined market value
- TRY 189.79T
- Countries
- 1
- Not ranked
- 8no revenue on file
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | TRY 4.76T | TRY 33.06T | TRY 13,731.29 | 1.65% up | 31% up | ||
| 2 | Eli LillyLLY · Health Care | TRY 3.3T | TRY 60.88T | TRY 68,349.26 | 0.04% up | 28% up | ||
| 3 | Merck & CoMRK · Health Care | TRY 3.29T | TRY 16.77T | TRY 6,803.83 | 1.31% up | 36% up | ||
| 4 | PfizerPFE · Health Care | TRY 3.16T | TRY 7.95T | TRY 1,394.34 | 0.13% up | 10% up | ||
| 5 | AbbVieABBV · Health Care | TRY 3.09T | TRY 25.78T | TRY 14,584.58 | 1.72% up | 20% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | TRY 2.44T | TRY 6.12T | TRY 2,991.95 | 1.42% up | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | TRY 2.24T | TRY 9.07T | TRY 5,237.06 | 0.29% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | TRY 725.3B | TRY 4.83T | TRY 46,647.59 | 0.01% up | 22% up | ||
| 9 | ViatrisVTRS · Health Care | TRY 723.1B | TRY 1.14T | TRY 990.58 | 1.46% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | TRY 606.9B | TRY 6.64T | TRY 26,197.93 | 0.49% down | 22% up | ||
| 11 | ZoetisZTS · Health Care | TRY 478.7B | TRY 1.64T | TRY 4,026.52 | 1.44% down | 34% down | ||
| 12 | Elanco Animal HealthELAN · Health Care | TRY 238.4B | TRY 649.5B | TRY 1,299.53 | 2.24% down | 18% up | ||
| 13 | Alnylam PharmaceuticalsALNY · Health Care | TRY 187.8B | TRY 987.8B | TRY 7,374.96 | 1.33% down | 66% down | ||
| 14 | BioMarin PharmaceuticalBMRN · Health Care | TRY 162.9B | TRY 589.2B | TRY 3,042.01 | 2.05% down | 12% up | ||
| 15 | United TherapeuticsUTHR · Health Care | TRY 160.9B | TRY 1.19T | TRY 27,963.17 | 1.09% down | 18% up | ||
| 16 | Amneal PharmaceuticalsAMRX · Health Care | TRY 152.6B | TRY 374.4B | TRY 1,074.51 | 0.65% down | 79% up | ||
| 17 | Royalty PharmaRPRX · Health Care | TRY 120.3B | TRY 1.99T | TRY 3,460.44 | 1.06% up | 74% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | TRY 87.5B | TRY 239.1B | TRY 2,862.00 | 2.96% down | 26% down | ||
| 19 | Legend BiotechLEGN · Health Care | TRY 52B | TRY 151.8B | TRY 782.75 | 3.85% down | 43% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 48.5B | TRY 451.8B | TRY 19,450.74 | 3.04% down | 28% down | ||
| 21 | Ionis PharmaceuticalsIONS · Health Care | TRY 47.7B | TRY 226.7B | TRY 1,361.22 | 1.10% down | 64% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 41.9B | TRY 298.3B | TRY 2,109.84 | 4.41% down | 8% up | ||
| 23 | Corcept TherapeuticsCORT · Health Care | TRY 38.5B | TRY 348.1B | TRY 3,180.56 | 3.20% down | 16% down | ||
| 24 | Axsome TherapeuticsAXSM · Health Care | TRY 32.3B | TRY 343.5B | TRY 6,530.52 | 4.81% down | 9% down | ||
| 25 | TG TherapeuticsTGTX · Health Care | TRY 31.2B | TRY 484.2B | TRY 3,203.32 | 2.36% down | 103% up | ||
| 26 | InsmedINSM · Health Care | TRY 30.7B | TRY 1.58T | TRY 7,185.34 | 1.63% down | 27% down | ||
| 27 | Mirum PharmaceuticalsMIRM · Health Care | TRY 26.4B | TRY 321.2B | TRY 4,920.52 | 1.88% up | 35% up | ||
| 28 | BridgeBio PharmaBBIO · Health Care | TRY 25.4B | TRY 748.8B | TRY 3,843.73 | 2.77% down | 15% up | ||
| 29 | Travere TherapeuticsTVTX · Health Care | TRY 24.8B | TRY 230.3B | TRY 2,399.58 | 1.75% down | 39% up | ||
| 30 | Ligand PharmaceuticalsLGND · Health Care | TRY 13.6B | TRY 289.8B | TRY 14,489.01 | 0.14% down | 44% up | ||
| 31 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 9.6B | TRY 397.4B | TRY 5,731.59 | 2.95% down | 15% up | ||
| 32 | CytokineticsCYTK · Health Care | TRY 4.5B | TRY 359.7B | TRY 2,582.12 | 0.77% down | 21% down | ||
| 33 | Protagonist TherapeuticsPTGX · Health Care | TRY 2.3B | TRY 403.8B | TRY 6,186.17 | 1.35% down | 45% up | ||
| 34 | Dianthus TherapeuticsDNTH · Health Care | TRY 103M | TRY 238.7B | TRY 4,238.14 | 1.20% down | 105% up | ||
| 35 | Spyre TherapeuticsSYRE · Health Care | TRY 0 | TRY 451.2B | TRY 4,750.62 | 3.77% down | 302% up | ||
| 36 | Praxis Precision MedicinesPRAX · Health Care | TRY 0 | TRY 428.5B | TRY 15,330.17 | 2.48% down | 83% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.5654 TRY). 8 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies in the United States rank first by revenue?
Johnson & Johnson (TRY 4.76T), Eli Lilly (TRY 3.3T) and Merck & Co (TRY 3.29T) are the top three of the 36 pharmaceutical companies in the United States ranked by revenue as of 20 Nov 2026, 20:09 UTC.
How many pharmaceutical companies in the United States are in this ranking?
36 are ranked by revenue. 8 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies in the United States worth together?
The 36 pharmaceutical companies in the United States ranked by revenue have a combined market value of TRY 189.79T as of 20 Nov 2026, 20:09 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by revenue”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.